Spotlight On... Secretive Stanford startup closes $18M VC round for wearable to treat hand tremors; Startup wins FDA nod to enable procedures on ultrasound; FDA clears BD blood collection set; and more...

Cala Health has raised $18 million for its investigational wearable technology to treat hand tremors, SEC filings show. Backers include Johnson & Johnson ($JNJ) Development Corporation, Lux Capital and Lightstone Ventures. More

@FierceMedDev: ICYMI yesterday: GSK partners with Belgian neurostim startup in bioelectronic medicine research. Article | Follow @FierceMedDev

@EmilyWFierce: Kentucky lawmaker proposed a bill that would require men to get a note from their spouse for a Viagra Rx. NYT story | Follow @EmilyWFierce

> Masimo gained FDA clearance for its noninvasive blood pressure and temperature measurements for the Root patient monitoring and connectivity platform. More

> Baltimore-based startup Clear Guide Medical won an FDA nod for its SCENERGY Ultrasound-CT Fusion System that is says is the first to enable interventional procedures using existing ultrasound machines. More

> The FDA cleared a new blood collection set from Becton Dickinson ($BDX) designed for use in patients with difficult to access veins. More

Biotech News

@FierceBiotech: Survey: Biopharma gets a bad grade on gender diversity. Report | Follow @FierceBiotech

@JohnCFierce: It's been fun watching the traffic/responses on the gender issue last few wks. There's a whole segment of the male audience tuning it out. | Follow @JohnCFierce

@DamianFierce: happy birthday to Wizards legend Michael Jodran. | Follow @DamianFierce

> Roche and AstraZeneca snag 'breakthrough' tags for a pair of blockbusters in waiting. Article

> Flexion's pain drug comes through in Phase III after a prior pivotal failure. News

> Catalyst hits an FDA roadblock with its 'breakthrough' rare disease drug. More

> Orbimed helps bankroll Synlogic's drive to the clinic with $40M round. Report

Pharma News

@FiercePharma: ICYMI yesterday: With pricing power waning, time for Big Pharma to become a lean, mean, well-oiled machine. Article | Follow @FiercePharma

@EricPFierce: Merck adding a couple hundreds manufacturing jobs in Ireland. FiercePharmaManufacturing article | Follow @EricPFierce

@CarlyHFierce: ICYMI: Express Scripts steps up its Valeant feud with microscopic look at every claim. Story | Follow @CarlyHFierce

> Pfizer whistleblowers set to collect $59M in Medicaid fraud suit. Article

> Pricey specialty meds get the DTC treatment even when target markets are small. Report

Biotech Research News

> Scientists use old vaccination method to beat new viruses. Article

> Johns Hopkins scientists create 'mini-brains' for neurodegeneration researchers. Story

> Penn team shines a light on creating brown fat to fight diabetes. Report

> Hype around worm study on potential Alzheimer's treatment is derided. Item

> Analysis: Scrap the NIH funding model and switch to a lottery. More

Vaccines News

> U.K. report: Vaccines could help in superbug fight. Item

> Walter Reed kicks off PhI trial of Inovio's MERS vaccine. News

> Sanofi ships 1M Dengvaxia doses to Philippines, in talks for 3M more at €20 a dose. Report

> Russia to test Ebola candidate in Guinea: AFP. Story

> NIH, Bharat Biotech hold the lead in Zika vaccine race: WHO. Article

Pharma Marketing News

> It's not just payers waiting on PCSK9 outcomes data. Doctors are holding back, too. Story

> Instagram updates could help pharma tap new audiences--and maybe get creative, too. Report

> Can BIO's heartfelt image campaign win hearts and minds? Pharma skeptics aren't convinced. More

> McCann Health adds new chief growth officer to get ahead in changing industry. Story

> Merck's new hep C contender Zepatier faces a long runway, but 2017 could bring takeoff. Article

Suggested Articles

BD will begin offering a point-of-care COVID-19 antibody assay, which operates like a combination of a blood glucose test and a home pregnancy test.

Smith+Nephew is contracting with the U.K. government to build a new ventilator specifically designed for large-scale production.

NantWorks’ ImmunityBio has begun a supercomputing collaboration with Microsoft to map out the spike protein of the novel coronavirus.